Targeting Disseminated Estrogen-Receptor-Positive Breast Cancer Cells in Bone Marrow

Estrogen receptor-positive (ER+) breast cancer can recur up to 20 years after initial diagnosis. Delayed recurrences arise from disseminated tumors cells (DTCs) in sites such as bone marrow that remain quiescent during endocrine therapy and subsequently proliferate to produce clinically-detectable m...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncogene
Prif Awduron: Buschhaus, Johanna M., Humphries, Brock A., Eckley, Samantha S., Robison, Tanner H., Cutter, Alyssa C., Rajendran, Shrila, Haley, Henry R., Bevoor, Avinash S., Luker, Kathryn E., Luker, Gary D.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7442734/
https://ncbi.nlm.nih.gov/pubmed/32678295
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-01391-z
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg